About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 257 record(s)
Req # A-2020-001840
Adverse Drug Reaction (ADR). Report number: E2B_03581369.Organization: Health Canada
June 2021
Req # A-2020-001841
Adverse Drug Reaction (ADR). Report number: E2B_03545704.Organization: Health Canada
June 2021
Req # A-2021-000299
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-104908-893, Meeting with Thoughtwire.Organization: Health Canada
June 2021
Req # A-2020-001748
Adverse Drug Reaction (ADR). Report number: E2B_03444012.Organization: Health Canada
June 2021
Req # A-2020-001773
Adverse Drug Reaction (ADR). Report number: E2B_03498705.Organization: Health Canada
June 2021
Req # A-2020-001924
Adverse Reaction Reports (AERs) for Abilify. Report numbers: E2B_03452264, E2B_03452286, E2B_03452288, E2B_03452296, E2B_03452301, E2B_03452302, E2B_03452319, E2B_03452360, E2B_03452382, E2B_03452517, E2B_03452588, E2B_03459113, E2B_03459121,…Organization: Health Canada
June 2021
Req # A-2020-001871
Adverse Drug Reaction (ADR) for Leflunomide. Report number: 000726887.Organization: Health Canada
June 2021
Req # A-2020-001798
The total amounts spent in connection with COVID-19 and/or the pandemic between February 28, 2020 and February 28, 2021: contracts related only to the pandemic/COVID-19). Overtime related to the pandemic/COVID-19. Total amount paid. All equipment/…Organization: Health Canada
May 2021
Req # A-2020-001803
Any documents related to any complaints or investigations that have been filed or undertaken in respect of these companies in accordance with the Canadian Consumer Product Safety Act and its regulations. Randolph Edition Inc. NEQ: 1173704918…Organization: Health Canada
May 2021
Req # A-2020-001915
The analysis that is referenced in The Canada Gazette for 2 amendments to the Patented Medicines Regulations that include a note on the requirement for a GBA+ analysis, specifically: "Gender-based analysis plus: No gender-based analysis plus (…Organization: Health Canada
May 2021